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Abstract 28 
Background. Transcatheter ablation is the most effective treatment for patients with symptomatic 29 
or high-risk accessory pathways (AP). At present, no clear recommendations have been issued on 30 
the optimal approach for left sided AP ablation. We performed this meta-analysis to compare the 31 
safety and efficacy of transaortic retrograde versus transseptal approach for left sided AP ablation. 32 
Methods and Results. MEDLINE/PubMed and Cochrane database were searched for pertinent 33 
articles from 1990 until 2016. Following inclusion/exclusion criteria application, 29 studies were 34 
selected including 2030 patients (1013 retrograde, 1017 transseptal) from 28 observational single 35 
Centre studies and one randomized trial. Patients approached by transseptal puncture presented a 36 
significantly higher acute success (98% vs. 94%, p=0.040). The incidence of late recurrences 37 
(p=0.381) and complications (p=0.301) did not differ among the two groups, but the pattern of 38 
complications differed: vascular complications were more frequent with transaortic retrograde 39 
approach, while cardiac tamponade was the main transseptal complication. No difference was noted 40 
in terms of procedural duration and fluoroscopy time (p=0.230 and p=0.980, respectively). Meta-41 
regression analysis showed no relation between year of publication and acute success (p=0.325) or 42 
incidence of complications (p=0.795); additionally, no direct relation was found between age and 43 
acute success (p=0.256) or complications (p=0.863). 44 
Conclusions. Left sided AP transcatheter ablation is effective in around 95% of the cases, with a 45 
very limited incidence of complications. Transseptal access provides higher acute success in 46 
achieving AP ablation; late recurrences are rare but observed similarly following both approaches. 47 
Retrograde approach is affected by a relatively high incidence of vascular complications. 48 
Abstract word count: 250 49 
 50 
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Introduction 52 
Wolff-Parkinson-White syndrome is characterized by the concomitant presence of cardiac pre-53 
excitation and arrhythmias as atrio-ventricular re-entrant tachycardia or atrial fibrillation (AF). Less 54 
than 1% of patients with cardiac pre-excitation may present a significant risk of sudden cardiac 55 
death, due to very high conduction properties of the atrioventricular accessory pathway (AP) [1]. 56 
Treatment is warranted to prevent this risk of sudden death in high-risk asymptomatic patients, or to 57 
prevent re-entrant tachycardias in symptomatic patients [2,3].  58 
The APs can be situated everywhere in the tricuspid or mitral annuli, with the exception of the 59 
mitral-aortic continuity. Transcatheter ablation of the AP is the most effective treatment for patients 60 
affected by Wolff-Parkinson-White syndrome and for high-risk asymptomatic pre-excitation. The 61 
most recent guidelines recommend transcatheter ablation as first-line treatment for these patients 62 
[2], due to its high efficacy and safety in experienced Centres. 63 
Bearing in mind the different possible localizations, right APs can be approached for ablation from 64 
the femoral or subclavian veins, while left sided APs can be approached by transaortic retrograde 65 
pathway or transseptal puncture. These two approaches differ in terms of technique, materials, 66 
potential complications and easy access to the AP, and are usually chosen alternatively according to 67 
the operators’ comfort level and preference. However, no clear recommendation has been proposed 68 
on the ideal approach for transcatheter ablation of left sided APs. In particular, common practice is 69 
mainly based on single-Centre, observational studies, and no large randomized trials or registries 70 
have been published. 71 
We therefore performed this systematic review and meta-analysis including randomized and 72 
observational studies comparing the outcome of transaortic retrograde versus transseptal approach, 73 
aiming to assess the optimal approach for left sided AP transcatheter ablation, in terms of both 74 
safety and efficacy. 75 
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Materials and Methods 76 
Search strategy and studies selection 77 
The present study was conducted in accordance with current guidelines, including the recent 78 
Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) [4] amendment to 79 
the Quality of Reporting of Meta-analyses (QUOROM) statement, as well as recommendations 80 
from The Cochrane Collaboration and Meta-analysis Of Observational Studies in Epidemiology 81 
(MOOSE) [5]. All subjects included in the studies gave informed consent. 82 
MEDLINE/PubMed and Cochrane database were searched for pertinent articles published in 83 
English from 1990 until December 2016. The following terms: (“Left accessory pathway” OR “left 84 
Wolff Parkinson White”) AND “catheter ablation” AND “radiofrequency” were used. Retrieved 85 
citations were screened through abstract reading independently by two reviewers (M.M. and A.S.), 86 
and divergences resolved after consensus. If the citations were deemed potentially pertinent, they 87 
were then appraised as complete full-text reports according to the following explicit selection 88 
criteria: (i) human observational or randomized studies, (ii) published in English between 1990 and 89 
2016, (iii) investigating patients with left accessory pathways, (iv) including any duration of follow-90 
up. Exclusion criteria were (one enough for exclusion): (i) non-human setting, (ii) duplicate 91 
reporting (in which case the manuscript reporting the largest sample of patients was selected), (iii) 92 
case reports or papers including less than 10 patients; (iv) surgical AP ablation. Data concerning 93 
study design and year of publication, population characteristics, intervention, complications, acute 94 
and mid- or long-term outcome were extracted by two Authors and reviewed independently by a 95 
third one (M.A.), being inserted in a single study database. 96 
 97 
 98 
 99 
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Statistical analysis 100 
Since most of the included studies had an observational design, meta-analysis and meta-regressions 101 
were performed using random effect models. Primary outcomes of this systematic review were: 102 
proportions of initial success (calculated as the ratio between successful procedures and number of 103 
patients or as the ratio between successfully ablated pathways and the total number of treated 104 
pathways), proportion of recurrences after a mid-term follow-up and proportion of complications. 105 
Secondary outcomes were: total procedural time, fluoroscopy time (excluding those studies 106 
characterized by a “zero-fluoroscopy” approach) and number of energy applications per procedure. 107 
Meta-analysis of proportions was performed using STATA command “metaprop” [6], while meta-108 
analysis of continuous variables was performed using STATA command “metan” [7]. Aiming to 109 
assess the impact of the type of procedural access (retrograde aortic vs transseptal), subgroup meta-110 
analysis was performed for both primary and secondary outcomes and a Q test for heterogeneity 111 
between subgroups was computed. In addition, aiming to reduce the impact of potential biases 112 
derived from patients’ characteristics or year of publication, using the primary outcomes as 113 
dependent variables, pre-specified meta-regression analysis was performed through STATA 114 
command “metareg” [8] to test whether interactions with (i) year when the study was published and 115 
(ii) mean age of study participants were present.  116 
Continuous variables were reported as mean (standard deviation) and categorical variables as counts 117 
(percentage). Statistical analysis was performed using STATA version 12.0 (StataCorp, College 118 
Station, TX, USA), considering p values < 0.05 statistically significant.  119 
 120 
 121 
 122 
 123 
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Results 124 
Search Results 125 
The search identified 269 abstracts referring to transcatheter ablation of left sided APs; among this 126 
group, 233 were excluded following application of the inclusion and exclusion criteria; 36 of them 127 
were selected and full text was read by two Authors; 7 were excluded because reporting repeated 128 
data. Twenty-nine studies were finally included meeting all the pre-specified inclusion criteria. All 129 
included articles were single-Centre studies; overall 28 observational studies and one randomized 130 
trial were included. Complete details of the study flow-chart are described in in the Supplementary 131 
Material, Supplementary Figure 1. 132 
First Author, study design, publication date and complete main characteristics of each included 133 
study are reported in the Supplementary Material, Supplementary Table 1 [9-37]. 134 
Overall, 2030 patients have been included in the analysis, 1013 approached by retrograde 135 
transaortic access and 1017 by transseptal puncture. Baseline characteristics of the included 136 
population in both groups are described in Table 1. Briefly, population included mainly young 137 
adults, two thirds of whom were males. The most common location for left sided AP was left 138 
lateral, followed by left posterior. 139 
 140 
Efficacy and safety endpoints 141 
As shown in Figure 1, patients approached by transseptal puncture presented a significantly higher 142 
acute success of the ablation (98% vs. 94%, p=0.040) compared to transaortic retrograde approach. 143 
Conversely, the incidence of late recurrences of cardiac pre-excitation did not differ significantly 144 
among the two groups (3% vs. 2%, p=0.381; Figure 2). Concerning safety, the incidence of overall 145 
complications was equally low in both groups (0.4% vs. 1.2%, p=0.301; Figure 2). Of note, 146 
complications pattern was different: vascular complications (hematoma, pseudoaneurysm, aortic 147 
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regurgitation and coronary damage) were more frequent with transaortic retrograde approach, while 148 
cardiac tamponade was the main complication of transseptal approach. Detailed complications are 149 
reported in the Table 2. 150 
Additionally, procedural duration and fluoroscopy time were investigated, and no difference was 151 
noted between the two groups (p=0.230 and p=0.980, respectively; Figure 2). 152 
Aiming to assess the impact of the currently available knowledge and technologies employed for 153 
transcatheter ablation on the outcome and complications of the procedure, a meta-regression 154 
analysis was performed to assess the impact of year of publication, showing no relation between 155 
year of publication and acute success (p=0.325) or incidence of complications (p=0.795). 156 
Additionally, due to the wide age range of the included patients, varying from children to middle 157 
age, a meta-regression analysis was performed to assess the impact of age (Supplementary Figure 158 
2), showing no direct relation with acute success (p=0.256) or complications (p=0.863). 159 
 160 
 161 
 162 
 163 
 164 
 165 
 166 
 167 
 168 
 169 
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Discussion 170 
The present meta-analysis, although mainly based on single high-volume Centres, observational 171 
studies, includes the largest series of patients comparing the outcome of left sided AP transcatheter 172 
ablation approaching alternatively by transseptal or retrograde transaortic access. This series 173 
emerges due to the absence of large randomized trials or prospective registries assessing the 174 
comparison between the two approaches for left sided AP ablation, resulting a potentially useful 175 
tool to help Electrophysiologists in planning the access for left sided APs catheter ablation 176 
procedures. 177 
Overall, transseptal approach reported a higher acute success compared to transaortic retrograde 178 
approach. In fact, in experienced Centres transseptal approach may lead to easier manoeuvrability 179 
of the ablation catheters in the left atrium, compared to the more challenging manipulation 180 
approaching from the left ventricle across the aortic arch. Additionally, a more direct approach, as 181 
conferred by transseptal access through the catheter “entrapment” within the interatrial septum, may 182 
result in improved catheter stability and optimal contact on the mitral annulus, leading to a more 183 
effective radiofrequency delivery towards the left sided AP. Failure of an ablation attempt is in fact 184 
usually related to a suboptimal catheter stability and catheter-tissue contact during ablation. Of note, 185 
the only randomized trial included in the analysis, limited by the very small case sample (only 22 186 
patients), did not find any difference between the two approaches [32].  187 
Concerning recurrence of conduction over the AP, the incidence was limited between both groups, 188 
without significant difference. In fact, the mechanism leading to recurrence is related to a transient 189 
effect provided by suboptimal site of ablation, along with the oedema generated by the energy 190 
delivery [38]. The majority of difficulties for obtaining good stability through the transaortic 191 
approach seem therefore to impair acute efficacy, while the incidence of recurrences, although rare, 192 
occurs similarly with both approaches. 193 
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The overall incidence of complications did not differ between the two groups. It should be noted 194 
that pattern of complication is different, as transaortic approach was affected by a significantly 195 
higher incidence of vascular complications, while pericardial effusion was the most common 196 
complication following transseptal approach (although not reaching statistical significance, see 197 
Suppl Table 2). However, transseptal puncture needs specific training, and some Electrophysiology 198 
labs are not trained for this approach and therefore mandatorily manage left sided AP by transaortic 199 
approach. Of note, the number of transseptal access publications increased during recent years: this 200 
trend probably relates to the spread of left atrial ablation for atrial fibrillation, which increasingly 201 
favours the comfort level for transseptal puncture. However, in the absence of specific training, 202 
transseptal access may provide additional risk; therefore, the results of this analysis should not be 203 
generalized to all Electrophysiology Centres. 204 
Of note, the overall incidence of complications did not differ compared to the incidence reported for 205 
other left-sided arrhythmias ablation approached by transseptal access [39]. Additionally, also 206 
vascular complications were comparable to those reported by other electrophysiological procedures 207 
[39], although higher than those reported by coronary artery interventional procedures, probably 208 
related to the need of anticoagulation during the procedure. Conversely, thromboembolic events did 209 
not differ between the two approaches, highlighting that this is not an access-related complication. 210 
The meta-regression analysis, performed to assess the impact of the available knowledge and 211 
technologies on the outcome of accessory pathway ablation, showed no significant relation between 212 
acute efficacy or complications and year of publication. This finding suggests that left sided AP 213 
ablation can be safely and effectively performed even using conventional diagnostic and ablation 214 
catheters. In fact, although being related to reduction of radiological exposure for patients and 215 
physicians (40), the impact on the outcome of AP ablation seems not to be relevant, as previously 216 
reported concerning atrial fibrillation ablation. Of note, the overall procedural duration and the 217 
fluoroscopy time did not differ between the two approaches. Due to the different tools and 218 
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technologies, both approaches reported a wide range of both procedural duration and radiological 219 
exposure, which appear shorter in the most recent publications. However, decreasing procedural 220 
and fluoroscopy durations were parallel between the two approaches, demonstrating that both 221 
access types benefit from technological improvements in terms of global simplification and 222 
shortening of the procedure, but not in terms of safety or efficacy. 223 
Finally, age was not related to different outcome, in terms of both safety and efficacy. This finding 224 
emphasizes that left sided AP ablation can be safely performed even in children, in case of clear 225 
indication to perform catheter ablation, such as in case of symptomatic, high anterograde 226 
conduction APs. 227 
 228 
Limitations 229 
The present analysis includes a large and heterogeneous group of single Centre, observational 230 
studies: although heterogeneity was appraised by random effect, the inclusion of non-randomized, 231 
retrospective studies may limit the reproducibility of the results. Although excluding case samples 232 
and very small series, the experience of each single Centre in performing transcatheter ablation 233 
procedures or even left chambers access, including individual operators’ comfort level with both the 234 
approaches, may have affected the access choice and the outcome of each single study results. 235 
Additionally, publication bias cannot be excluded, as a more favourable outcome would have driven 236 
the potential interest for publication of these series, compared to other single-Centres series that did 237 
never reach publication. However, it should be noted that parameters as year of publication, or age 238 
of the included patients, did not affect safety or efficacy of the ablation procedure. Finally, meta-239 
regression analysis does not allow clinicians to drive causative inferences, but only speculative. 240 
 241 
 242 
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Conclusion 243 
Left sided AP transcatheter ablation is effective in around 95% of the patients in trained operators 244 
hands, and can be performed with a very limited incidence of complications even in younger 245 
patients, when indicated. Transseptal access provides a higher acute success in achieving left sided 246 
AP ablation, while late recurrences are limited, but occur similarly following both approaches. 247 
While procedural duration and fluoroscopy use are similar, retrograde approach is affected by a 248 
relatively higher incidence of vascular complications. 249 
 250 
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Figure legends 258 
Figure 1. Acute success (A; 2030 patients from 29 studies) and incidence of recurrences (B; 1338 259 
patients from 23 studies) following left-sided accessory pathways ablation. 260 
Figure 2. Complications of left-sided accessory pathways ablation (1750 patients from 23 studies), 261 
procedural duration (1238 patients from 22 studies) and fluoroscopy times (1108 patients from 18 262 
studies) of left-sided accessory pathways transcatheter ablation procedures. 263 
264 
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Table 1. Pooled clinical features of included studies (2030 patients, 29 studies).  265 
 Transseptal approach 
(1017 patients) 
Transaortic approach 
(1013 patients) 
p-value 
Age, years (IQR) 27.8 (17.9-37.6) 34.5 (30.1-39.0) 0.10 
Males, % (IQR) 67 (62-72) 67 (59-65) 0.90 
Concealed accessory pathways, % (IQR) 34 (20-48) 31 (8-59) 0.76 
Site of accessory pathway, % (IQR): 
- Left anterolateral (%) 
- Left lateral (%) 
- Left posterior (%) 
- Left posteroseptal (%) 
 
7 (0.0-15) 7 (2-11) 0.68 
54 (36-70) 67 (57-76) 0.08 
32 (20-44) 12 (4-21) 0.02 
7 (3-12) 14 (7-21) 0.60 
Symptoms, % (IQR): 
- AVRT (%) 
- AF (%) 
  
82 (38-100) 86 (76-95) 0.81 
13 (8-20) 31 (15-51) 0.05 
Acute success, % (IQR) 98 (96-100) 94 (90-97) 0.02 
Number of RF/Cryo applications, n (IQR) 6.7 (4.6-8.6) 6.1 (4.2-8.0) 0.63 
Procedural duration, min (IQR) 179.0 (139.7-218.3) 145.5 (109.2-181.8) 0.23 
Fluoroscopy time, min (IQR) 32.2 (19.0-45.3) 32.9 (22.7-43.1) 0.98 
Complications, % (IQR) 0.4 (0.0-1.2) 1.2 (0.3-2.6) 0.30 
Follow-up duration, months (IQR) 14.5 (10.8-18.1) 12.75 (9.4-16.1) 0.62 
Recurrences, % (IQR) 3.2 (1.6-6.1) 2.3 (0.5-4.6) 0.31 
AVRT: atrioventricular re-entrant tachycardia; AF: atrial fibrillation; RF: radiofrequency; Cryo: 266 
cryoablation; IQR: interquartile range. 267 
 268 
 269 
270 
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Table 2. Complication pattern reported by transseptal and retrograde transaortic approach 271 
 Transseptal approach 
(1017 patients) 
Transaortic approach 
(1013 patients) 
p-value 
Vascular complications (hematoma, 
pseudoaneurysm) 
0 8 0.03 
Cardiac tamponade 6 3 0.51 
Stroke/TIA 2 1 1.00 
Death 0 0 1.00 
Peripheral embolism 0 3 0.12 
Coronary artery dissection/infarction 1 3 0.37 
Mitral regurgitation 1 2 0.62 
Aortic regurgitation 0 4 0.06 
Aortic dissection 0 1 1.00 
TIA: transient ischemic attack. 272 
 273 
 274 
 275 
 276 
 277 
 278 
 279 
 280 
 281 
 282 
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